Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
November 06 2018 - 7:00AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a
member of the company’s senior management team will participate in
the following investor conferences during the fourth quarter and
early portion of the first quarter of 2019:
- JP Morgan – 2018 CEO Conference Call Series
Virtual/Conference Call (information to be provided by JP Morgan)
November 13, 2018
- Three Part Advisors – 2018 Southwest IDEAS
Investor Conference Dallas, TX November 14-15, 2018
- Piper Jaffray – 30th Annual Healthcare
Conference New York, NY November 27-29, 2018
- Mizuho – Global Mizuho Investor
Conference New York, NY December 3, 2018
- BMO Capital Markets – 2018 Prescriptions for
Success Healthcare Conference New York, NY December 12,
2018
- JP Morgan – 37th Annual Healthcare
Conference San Francisco, CA January 7-10, 2019
Presentation dates and times will be updated on the Emergent
website www.emergentbiosolutions.com under “Investors” as the
information becomes available.For these conferences, the company
will be webcasting its presentation, which may include a discussion
of the company's recent business developments as well as its most
recently reported financial results and guidance. The webcasts will
be available both live and by replay, accessible from the Emergent
website.
About Emergent BioSolutionsEmergent
BioSolutions Inc. is a global life sciences company seeking to
protect and enhance life by focusing on providing specialty
products for civilian and military populations that address
accidental, intentional, and naturally occurring public health
threats. We aspire to be a Fortune 500 company recognized for
protecting and enhancing life, driving innovation, and living our
values. Additional information about the company may be found at
www.emergentbiosolutions.com. Find us on LinkedIn and follow us on
Twitter @emergentbiosolu and Instagram @life_at_emergent.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280BurrowsR@ebsi.com
Media Contact:Lynn KiefferVice
President, Corporate
Communications240-631-3391KiefferL@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024